| |
 |
No
uniform system
in place
to determine
accurate
study budgets |
| |
|
Lack
of competitor
pricing data
from similar
clinical
trials |
| |
|
Hard
to implement
pricing standards
across therapeutic
teams |
| |
|
Gross
underestimating
of procedure
costs over
a lengthy
and complex
study |
| |
|
Lack
of procedure
cost comparisons
to alternative
sources of
revenue,
i.e. Medicare |